These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 185806)

  • 21. Signs of coronary atherosclerosis in apparently healthy men with different types of hyperlipoproteinaemia.
    Olsson AG
    Postgrad Med J; 1975; 51(8):40-3. PubMed ID: 1221379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyperlipoproteinemia type IIa. Serum lipoprotein pattern as influenced by diet and clofibrate].
    Mertz DP; Suermann I; Loewer H; Schmidt GG
    MMW Munch Med Wochenschr; 1979 Jun; 121(23):791-2. PubMed ID: 223044
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
    Millett F; Sielski J; Stoll H; Alston N; Gail S
    PA J; 1976; 6(2):54-9. PubMed ID: 10235781
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of the PSMF diet on plasma lipids and lipoproteins in obese subjects].
    Petrillo A; Chevaux F; Rohrer J; Darioli R
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1837-41. PubMed ID: 6515380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE; Lees RS
    J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperlipoproteinemia type IV and pre-beta-lipoprotein. Some new aspects of its physiology, pathogenesis and diagnosis.
    Wille LE
    J Oslo City Hosp; 1972; 22(11):169-84. PubMed ID: 4344735
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL; Schonfeld G; Weidman SW
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperlipoproteinemia in angiographically documented coronary artery disease.
    Eisenberg S; Tzivoni D; Stern S
    Eur J Cardiol; 1976 Dec; 4(4):469-73. PubMed ID: 187428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric familial type III hyperlipoproteinemia.
    Glueck CJ; Fallat RW; Mellies MJ; Steiner PM
    Metabolism; 1976 Nov; 25(11):1269-74. PubMed ID: 185489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of lipoprotein abnormalities in patients with peripheral vascular disease.
    Ballantyne D; Lawrie TD; Morgan HG
    Ann Biol Clin (Paris); 1973; 31(2):145-6. PubMed ID: 4356111
    [No Abstract]   [Full Text] [Related]  

  • 34. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
    Utermann G; Vogelberg KH; Steinmetz A; Schoenborn W; Pruin N; Jaeschke M; Hees M; Canzler H
    Clin Genet; 1979 Jan; 15(1):37-62. PubMed ID: 215360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
    Yoshida H; Hirowatari Y; Kurosawa H; Tada N
    Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Frequency and distribution of types of hyperlipoproteinemia with life-shortening risk factors among ambulant patients (author's transl)].
    Mertz DP; Hohneck A
    Med Klin; 1975 Jul; 70(28-29):1209-13. PubMed ID: 170497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)].
    Zöller H; Gross W
    MMW Munch Med Wochenschr; 1976 Apr; 118(16):493-4. PubMed ID: 178994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On a family with coexistence of phenotypes II and III hyperlipoproteinemia.
    Mariën KJ; Hulsmans HA; van Gent CM
    Acta Med Scand; 1974 Sep; 196(3):149-53. PubMed ID: 4370577
    [No Abstract]   [Full Text] [Related]  

  • 39. [Typology of the hyperlipoproteinemias in ischemic heart disease].
    Zakharova VN; Afanas'eva ON; Andrushchenko ES; Naumova LV; Zarudina IN
    Kardiologiia; 1977 Dec; 17(12):105-8. PubMed ID: 202776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 4 hyperlipoproteinemia: one theory of atherogenesis.
    Zelis R; Salel AF
    Chest; 1973 Oct; 64(4):486-90. PubMed ID: 4355275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.